Women’s Health Matters: Mastering Hormone Therapy

Credit

Handouts/Brochure

Speaker

Laura Swoboda, DNP, APNP, FNP-BC, FNP-C, CWSP Related seminars and products

---

Laura Swoboda, DNP, APNP, FNP-BC, FNP-C, CWSP, is a family nurse practitioner and translational scientist at SkinGurus in Milwaukee, WI. Dr Swoboda is on the editorial board of American Nurse Journal, the official journal of the American Nurses Association, and WOUNDS journal. They represent North America on the International Skin Tear Advisory Panel and are President of the Milwaukee Metro Nurse Practitioner Association. Dr Swoboda has won two career lifetime achievement awards under the age of forty as a fellow of both the American Association of Nurse Practitioners and the Wound Ostomy Continence Nurses Association.   

 

Speaker Disclosures:
Financial: Dr. Laura Swoboda has employment relationships with Third Coast Vascular, MCHC, Cathage College, Skin Gurus, and The Healing Institute. She receives a speaking honorarium and consulting fee from Histologics, Hartmann, HMP, Essity, Convatec, Aroa, AOTI, Innovacyn, Solventum, Smith & Nephew. Dr. Swoboda receives a speaking honorarium and recording royalties from PESI, Inc.
Non-financial: Dr. Laura Swoboda serves on the board of directors for the Wound Ostomy Continence Certification Board. She is an editorial board member of Wound Care Learning Network. Dr. Swoboda previously was a consultant for Essity and Innovacyn.

Additional Info

Access never expires for this product.

Visit our FAQ page at www.pesi.com/faq or contact us at www.pesi.com/info

Objectives

1. Discuss key terms as they relate to menopause and menopausal hormone therapy.
2. List symptoms of menopause and expected response to estrogen therapy.
3. Compare risks and benefits of menopausal hormone therapy.
4. Describe hormone cessation recommendations.

Outline

• Reproductive endocrine function
• Stages of reproductive aging
• Menopause definition and diagnosis
• Menopause evaluation
• >45, <45
• Ruling out secondary amenorrhea
• Thyroid and menopause
• TSH
• Prolactin
• FSH
• Menopause Symptoms
• Respond to estrogen y/n
• Weight gain
• Neurological
• Hormone Therapy
• Goal
• Epidemiology
• Disease prophylaxis
• Checklist
• Benefits v risks
• Osteoporosis
• Heart disease and stroke
• Blood clots
• Breast cancer
• Estrogen absorption
• Systemic effects
• Endometrial hyperplasia
• Risk mitigation
• Hormone Therapy
• Tips and tricks application
• Molecule structure and action
• Synthetic and natural estrogens
• Estradiol
• CEE
• SERMs
• Progesterone
• Compounds and biosimilars
• FDA approval
• Menopausal Hormone Therapy
• Systemic
• Low-dose vaginal
• Combination
• Adverse effects
• Monitoring
• Contraindications
• Toxicity
• Interactions
• Box Warning
• Vehicles: pellets, etc
• Genitourinary Syndrome of Menopause
• Urogenital atrophy and vestibular glands
• Symptoms
• Vaginal preparations
• Adjuncts
• Ospemifene (SERMS)
• Case avoidance
• Testosterone
• Hormone Cessation
• Menopausal adjuncts and supplements
• Prescriptive vasomotor symptom coverage
• Sexual dysfunction
• Vaginal rejuvenation
• Herbal and OTC
• Safety and efficacy
• Commonly used agents
• Nutrients and vitamins
• Off-label estrogen use
• Skin care
• Case Exemplars

Target Audience

• Nurses
• Nurse Practitioners
• Physician Assistants
• Physicians